key: cord-0748170-htudm2l2
authors: Elliott, Jessie A; Kenyon, Robert; Kelliher, Gerry; Gillis, Amy E; Tierney, Sean; Ridgway, Paul F
title: Response to: “Comment on: Nosocomial SARS-CoV-2 transmission in postoperative infection and mortality: analysis of 14 798 procedures”
date: 2021-04-22
journal: Br J Surg
DOI: 10.1093/bjs/znab083
sha: 2f56b4ef7160bde81eb9af49c996e59fed081ee1
doc_id: 748170
cord_uid: htudm2l2

nan

We thank the authors for their consideration of our paper 1 and note their comments with respect to the included surgical procedures, the sociodemographic factors impacting risk of SARS-CoV-2 and the impact of infection mitigation measures.

Firstly, we agree that surgeons working in acute care surgery may be at increased risk for exposure to SARS-CoV-2, and for this reason common acute care surgical procedures were included, as shown in Table S2 .

Secondly, with respect to sociodemographic factors, we wish to highlight that the aim of the study, rather than provision of individualised risk assessments, was to provide insights into the impact of nosocomial transmission rates on outcomes across a range of surgical procedures. These data provide a tool to facilitate surgical planning, at a time when decisions regarding the provision of elective and cancer surgery are of major importance. In addition, surgical technique (here classified as open or laparoscopic) was assessed as demonstrated in Tables S2, S3 and S4.

In relation to the impact of mitigation strategies, it should be noted that the present study utilised NQAIS data to estimate the probability of SARS-CoV-2 infection and mortality given a known nosocomial transmission risk. Nosocomial transmission risk may indeed be impacted by mitigation strategies, and our data hence underscore the critical importance of infection prevention and control strategies to minimise nosocomial transmission, and associated morbidity and mortality.

Lastly, we recognise that the current data represent experience in a European, publicly-funded health system, and that results may not be generalisable to other health systems. We agree that future studies may assess the impact of nosocomial transmission risk in low-and middle-income countries, and ongoing collaborative efforts such as COVIDSurg may address this question.

Funding: None

Nosocomial SARS-CoV-2 transmission in postoperative infection and mortality: analysis of 14 798 procedures

All rights reserved. For permissions

Supplementary material is available at BJS Open online.